PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
R Belfort Selected Research
Ocular Toxoplasmosis
09/2008
Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis.
09/2006
Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis.
Articles by Research Topic
Disease
2
Ocular Toxoplasmosis
09/2008 - 09/2006
1
Uveitis
08/2007
1
Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
02/2006
1
Choroidal Neovascularization
10/2001
1
Macular Degeneration (Age-Related Maculopathy)
10/2001
1
Myopia
08/2001
1
Keratoconjunctivitis
03/2001
1
Acquired Immunodeficiency Syndrome (AIDS)
03/2001
1
Cytomegalovirus Retinitis
07/2000
1
Toxoplasmosis
06/2000
1
Congenital Toxoplasmosis
06/2000
Drug/Important Bio-Agent (IBA)
2
Triamcinolone Acetonide (Azmacort)
FDA Link
Generic
09/2008 - 09/2006
1
Interleukin-12 (IL 12)
IBA
08/2007
1
Mitochondrial DNA (mtDNA)
IBA
02/2006
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
10/2001
1
Ganciclovir (Cytovene)
FDA Link
Generic
07/2000
1
Antigens
IBA
06/2000
Therapy/Procedure
1
Photochemotherapy (Photodynamic Therapy)
10/2001
1
Intraocular Lenses (Intraocular Lens)
08/2001
1
Highly Active Antiretroviral Therapy (HAART)
03/2001